- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01459172
Human Breast Tissue Bioavailability of Topically Applied Limonene
April 19, 2016 updated by: University of Arizona
The overall objective of this project is to determine the safety and breast tissue bioavailability of limonene following massage application of limonene containing massage oil to the breast.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
103
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85724
- The University of Arizona Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women who are 18-65 years of age
- ECOG performance status 0-1
- Normal organ and marrow function
- Women of child-bearing potential must agree to use adequate contraception
- Willing to avoid consumption and use of citrus or citrus containing products throughout the study
- Have both breasts intact
Exclusion Criteria:
- Have had cancer(s) within the past 5 years
- Participated in another clinical interventional trial within the past 3 months
- Uncontrolled intercurrent illness
- Pregnant or breast feeding
- Unable to produce nipple aspirate fluid
- Have known allergic or sensitive reactions to skin care products, citrus or coconut oil
- Have ongoing skin disorders such as eczema and psoriasis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Limonene intervention
|
daily massage application to the breast for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
breast tissue bioavailability
Time Frame: 4 weeks
|
limonene levels in nipple aspirate fluid after 4 weeks of intervention
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
safety
Time Frame: 6 weeks
|
number of participants with adverse events
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Sherry Chow, Ph.D., The University of Arizona
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (Actual)
February 1, 2010
Study Completion (Actual)
March 1, 2010
Study Registration Dates
First Submitted
October 20, 2011
First Submitted That Met QC Criteria
October 21, 2011
First Posted (Estimate)
October 25, 2011
Study Record Updates
Last Update Posted (Estimate)
April 21, 2016
Last Update Submitted That Met QC Criteria
April 19, 2016
Last Verified
October 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-0375-04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.